NetworkNewsBreaks

WednesdayOct 26, 2016 1:48 pm

Tonix Pharmaceuticals Holding Corp. (TNXP) Prices $5.2M Public Offering, Shares Sharply Lower

Shares of Tonix Pharmaceuticals (NASDAQ: TNXP) are down 21% in mid-day trade. The company this morning announced the pricing of an underwritten public offering of common stock and warrants at an offering price of $0.55 per unit. The company said it plans to use the gross proceeds of approximately $5.2 million to support the continued development of TNX-102 SL for the treatment of posttraumatic stress disorder (PTSD), including completion of the first interim analysis in the phase 3 study in military-related PTSD, to further develop other pipeline programs, for working capital and other general corporate purposes. To view the press…

Continue Reading

WednesdayOct 26, 2016 1:47 pm

Ritter Pharmaceuticals, Inc. (RTTR) Shares Higher on $5M Public Offering

Ritter Pharmaceuticals (NASDAQ: RTTR) is trading more than 10% higher mid-day after the company this morning priced an underwritten public offering of 2,127,660 shares of its common stock at a price to the public of $2.35 for gross proceeds of approximately $5 million. The offering is expected to close on October 31, 2016, subject to customary closing conditions. To view the press release, visit:  http://nnw.fm/tyL4U About Ritter Pharmaceuticals, Inc. Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Company is advancing human gut health research by exploring the metabolic capacity of…

Continue Reading

WednesdayOct 26, 2016 1:46 pm

Amyris (AMRS) Inks Collaboration Deal with Global Nutraceuticals Partner, Q3 Results Ahead

Amyris (NASDAQ: AMRS) this morning announced definitive agreements for its strategic partnership and financing with a global nutraceuticals market leader, as previously described in September. As a result of new markets and products stemming from the collaboration, the industrial bioscience company forecasts annual revenue of roughly $100 million at full-scale production expected in 2019. Amyris is scheduled to post its third-quarter results November 2, 2016. To view the full press release, visit: http://nnw.fm/1oIGZ About Amyris Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to…

Continue Reading

WednesdayOct 26, 2016 12:31 pm

Innovation, Expansion Drive Net Element, Inc.’s (NETE) Success

Net Element (NASDAQ: NETE) continues to make its mark as a technology-driven company, expanding its presence as a payments-as-a-service transactional and value-added services company in the United States and in select emerging markets. Within its family of brands is Aptito, an all-in-one, cloud-based point of sale payments platform making waves in the restaurant industry. The company’s PayOnline subsidiary recently added ExLine and Dunkin’ Donuts to its growing client base, deepening its reach in the Russian payments market. To view more on this company visit http://nnw.fm/d9hMX About Net Element Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services…

Continue Reading

TuesdayOct 25, 2016 3:47 pm

Second Sight (EYES) Shares Soar on Implant and Activation of Wireless Visual Cortical Stimulator in First Human Subject

Shares of Second Sight Medical Products (NASDAQ: EYES) are moving higher on news that the implantable visual prosthetics company has successfully implanted and activated a wireless visual cortical stimulator in a human subject. The company said the achievement provides the initial human proof of concept for the ongoing development of the company’s Orion™ I Visual Cortical Prosthesis (Orion I). “Based on these results, stimulation of the visual cortex has the potential to restore useful vision to the blind, which is important for independence and improving quality of life,” Dr. Nader Pouratian, the UCLA neurosurgeon who performed the surgery, stated in…

Continue Reading

TuesdayOct 25, 2016 3:44 pm

Medical Transcription Billing Corp. (MTBC): Recent Acquisition is Catalyst for Sales Growth in 2017

Medical Transcription Billing (NASDAQ: MTBC; MTBCP) recently acquired MediGain LLC, marking the company’s largest acquisition to-date and one expected to significantly boost overall revenue in 2017. “The deal marks a major corporate milestone for MTBC and shows the power of its acquisition-based growth strategy … the revenue cycle management customer accounts and other assets acquired from MediGain have annual revenues of more than $10 million, which is expected to contribute significantly to Medical Transcription Billing’s revenue growth in 2017.” The deal also expands MTBC’s staff in North America, as well as in Asia. To view the full press article, visit: …

Continue Reading

TuesdayOct 25, 2016 1:04 pm

The Driving Force Behind SinglePoint, Inc.’s (SING) Best-in Class Mobile Commerce, Communication Solutions

With more than 20 years of experience in the technology sector, SinglePoint (OTC: SING) Chief Technology Officer Eric Lofdahl has helped craft the company’s best-in-class mobile commerce and communications solutions designed to help companies, nonprofits, and religious organizations seamlessly conduct business transactions, accept donations, and engage in targeted communication via smartphone. Lofdahl works in tandem with SinglePoint CEO Greg Lambrecht who previously founded PCI, a leading consumer product distribution company, and has negotiated agreements with the nation’s largest retail outlets, such as 7-11 (Southland Corp), Albertson’s, and Costco, representing 25,000 retail accounts. For more information, visit:  http://nnw.fm/Mmi9v About SinglePoint, Inc.…

Continue Reading

TuesdayOct 25, 2016 11:01 am

Towerstream Corporation (TWER) Shares Trend Higher on Plans to Double New Buildings

Towerstream (NASDAQ: TWER) this morning announced its plans to add 100 new buildings to its On-Net footprint in the fourth quarter, sending shares higher in early trade. “There is momentum in our business now,” Arthur Giftakis, chief operating officer, stated in the news release. “We accelerated our On-Net platform in Q1 of this year and already 48 percent of our buildings have multiple customers and several have more in this early stage of our expansion initiative.” The company also briefly discussed its pursuit of “select M&A transactions.” To view the full press release, visit: http://nnw.fm/rCpX5 About Towerstream Corporation Towerstream Corporation (NASDAQ:…

Continue Reading

TuesdayOct 25, 2016 11:00 am

Dipexium Pharmaceuticals, Inc. (DPRX) Shares Tumble on Disappointing Locilex® Phase 3 Studies

Shares of Dipexium Pharmaceuticals (NASDAQ: DPRX) plummeted more than 80% after the company reported that OneStep phase 3 clinical trials of its lead candidate Locilex® failed to meet primary or secondary endpoints in the treatment of mild infections of diabetic foot ulcers. "Although we are disappointed with these results, we are continuing to evaluate the data and will consider potential regulatory pathways forward in other possible clinical indications based on an evaluation of all data emerging from the phase 3 studies,” David P. Luci, president and CEO of Dipexium, stated in the news release. To view the full press release,…

Continue Reading

MondayOct 24, 2016 5:08 pm

Xplore Technologies Corp. (XPLR) Posts Preliminary Q2 Results, Expectations for Profitable Second Half

Xplore Technologies (NASDAQ: XPLR) this afternoon posted preliminary second-quarter results, updated its revenue outlook for fiscal 2017, and forecast second half profitability “to drive approximately breakeven net income for the full year.” “We anticipate revenue of approximately $20.0 million in our fiscal second quarter … As a result, we entered the December quarter with record backlog of more than $11 million,” Mark Holleran, Xplore’s president and chief operating officer, stated in the news release. The company guides revenue to be at the lower end of its initial $85 million to $95 million outlook. Full results are expected November 10. For…

Continue Reading